.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Citi
Novartis
UBS
US Department of Justice
US Army
Merck
Moodys
Deloitte
McKinsey

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202161

« Back to Dashboard
NDA 202161 describes DESONIDE, which is a drug marketed by Perrigo New York, G And W Labs Inc, Hi-tech Pharmacal, Taro, Fougera Pharms, and Taro Pharm, and is included in nine NDAs. It is available from eight suppliers. Additional details are available on the DESONIDE profile page.

The generic ingredient in DESONIDE is desonide. There are twenty-nine drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the desonide profile page.

Summary for NDA: 202161

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details

Pharmacology for NDA: 202161

Suppliers and Packaging for NDA: 202161

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DESONIDE
desonide
LOTION;TOPICAL 202161 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-4079 51672-4079-4 1 BOTTLE in 1 CARTON (51672-4079-4) > 59 mL in 1 BOTTLE
DESONIDE
desonide
LOTION;TOPICAL 202161 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-4079 51672-4079-8 1 BOTTLE in 1 CARTON (51672-4079-8) > 118 mL in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:LOTION;TOPICALStrength0.05%
Approval Date:Oct 31, 2014TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Baxter
Fish and Richardson
Argus Health
US Army
Mallinckrodt
Harvard Business School
Cipla
Cerilliant
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot